Please Enable Cookies to Continue
Please enable cookies in your browser to experience all the personalized features of this site, including the ability to apply for a job.
Here are our current job openings. Please click on the job title for more information, and apply from that page if you are interested.
Current Dendreon Employees: Please apply using the internal career site available through the intranet.
The system cannot access your location for 1 of 2 reasons:
- Permission to access your location has been denied. Please reload the page and allow the browser to access your location information.
- Your location information has yet to be received. Please wait a moment then hit [Search] again.
Click column header to sort
Who We Are:
At Dendreon, we’re transforming the battle against cancer with personalized immunotherapy. Our flagship product, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for metastatic castrate-resistant prostate cancer, utilizing a patient’s own immune cells to fight the disease.
Who we are:
At Dendreon, we’re revolutionizing cancer care through personalized immunotherapy. Our pioneering treatment, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for advanced prostate cancer. By activating a patient’s own immune system, we empower the body to fight back—offering real hope to those who need it most.
Who we are:
At Dendreon, we’re revolutionizing cancer care through personalized immunotherapy. Our pioneering treatment, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for advanced prostate cancer. By activating a patient’s own immune system, we empower the body to fight back—offering real hope to those who need it most.
Job Title
Senior Medical Science Liaison - Northwest (AK,WA, OR, ID,MT,WY,CO,ND,SD,NE,KS,MN,IA)
Who We Are:
At Dendreon, we’re transforming the battle against cancer with personalized immunotherapy. Our flagship product, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy for metastatic castrate-resistant prostate cancer, utilizing a patient’s own immune cells to fight the disease.
